Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Xavier Claramonte"'
Autor:
Omar Sued, Juan Ambrosioni, David Nicolás, Christian Manzardo, Fernando Agüero, Xavier Claramonte, Montserrat Plana, Montserrat Tuset, Tomás Pumarola, Teresa Gallart, José María Gatell, José María Miró
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131651 (2015)
Interventions during primary HIV infection (PHI) can modify the clinical course during the chronic phase. The long-term effect of structured treatment interruptions (STI) followed by low doses of interleukin-2 (IL-2) in treated PHI patients is unknow
Externí odkaz:
https://doaj.org/article/ae8f3b1c92c146339827228bf7b74fba
Autor:
María J. Jiménez-Expósito, Xavier Claramonte, M. Josa, J. Mulet, José L. Pomar, José M. Miró, Carlos A. Mestres, Ramón Cartañá
Publikováno v:
Revista Española de Cardiología. 59:276-279
La mayor supervivencia y los efectos metabolicos del tratamiento antirretroviral han aumentado el riesgo cardiovascular y la necesidad de cirugia coronaria en individuos positivos para el virus de la inmunodeficiencia humana (VIH). Comparamos la morb
Autor:
Xavier Claramonte, Miguel A Castro, Carlos A. Mestres, Javier E Chuquiure, Natividad Benito, Josefa Muñoz, José L. Pomar, José M. Miró
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 23:1007-1016
Objectives: Assessment of long-term results of immunodeficiency virus type-1 (HIV-1)-infected patients undergoing cardiac surgery. Methods: Retrospective analysis of profile and outcomes of 31 HIV-1-infected patients (35 operations, 1985‐ 2002). Re
Autor:
Marylène, Lejeune, José M, Miró, Elisa, De Lazzari, Felipe, García, Xavier, Claramonte, Esteban, Martínez, Esteban, Ribera, Julio, Arrizabalaga, José R, Arribas, Pere, Domingo, Elena, Ferrer, Montserrat, Plana, María-Eugenia, Valls, Daniel, Podzamczer, Tomás, Pumarola, Alain, Jacquet, Josep, Mallolas, José M, Gatell, Teresa, Gallart, Michèle, Haumont
Publikováno v:
CLINICAL INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background. It is unknown whether a Toxoplasma gondii-specific T cell response is restored after successful combined antiretroviral therapy (cART) in patients with AIDS and current or previous toxoplasmic encephalitis (TE). Methods. We performed a mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6bc978b4d2739fc975f5e09a038f55b
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12200
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12200
Autor:
Juan Ambrosioni, Tomás Pumarola, Christian Manzardo, Teresa Gallart, José M. Gatell, Montserrat Tuset, David Nicolás, Xavier Claramonte, Omar Sued, José M. Miró, Fernando Agüero, Montserrat Plana
Publikováno v:
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE, Vol 10, Iss 7, p e0131651 (2015)
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE, Vol 10, Iss 7, p e0131651 (2015)
Dipòsit Digital de la UB
Universidad de Barcelona
Background Interventions during primary HIV infection (PHI) can modify the clinical course during the chronic phase. The long-term effect of structured treatment interruptions (STI) followed by low doses of interleukin-2 (IL-2) in treated PHI patient
Autor:
María J, Jiménez-Expósito, Carlos A, Mestres, Xavier, Claramonte, Ramón, Cartañá, Miquel, Josa, José L, Pomar, Jaume, Mulet, José M, Miró
Publikováno v:
Revista espanola de cardiologia. 59(3)
The use of highly active antiretroviral therapy (HAART) in patients with HIV infection has improved survival. This improvement combined with the metabolic effects of treatment has increased cardiovascular risk and the need for cardiac surgery in thes
Autor:
José Peña, Daniel Podzamczer, Miguel Santin, J. C. López, Pere Domingo, José M. Miró, Xavier Claramonte, Esteban Martínez, Esteban Ribera, Jaime Cosín, Jose R. Arribas, Alberdi Jc, Gesida
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 43(1)
To our knowledge, no randomized trials have evaluated whether prophylaxis against toxoplasmic encephalitis can be safely discontinued after the CD4+ T cell count increases in response to highly active antiretroviral therapy.We conducted a randomized,
Autor:
G. Torres, Manuel Almela, Miró Jm, John R. Perfect, Francesc Marco, A. Moreno, N. Pérez, María J. Jiménez-Expósito, Natividad Benito, Carlos-A. Mestres, M. T. Jimenez de Anta, Wiley A. Schell, C. García de la Mària, Gatell Jm, Xavier Claramonte, J.C. Paré, A. Baraldés, G. R. Corey
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 39(7)
Conventional antifungal therapy for fungal endocarditis has been associated with a poor cure rate. Therefore, combined medical and surgical therapy has been recommended. However, new potent antifungal agents, such as echinocandins, could increase the
Autor:
Francesc Marco, A. del Río, Carlos-A. Mestres, A. Moreno-Camacho, Gatell Jm, Xavier Claramonte, M. Azqueta, Juan Emilio Losa, Miró Jm, Felipe García
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 9(1)
Objectives To add to the limited information on infective endocarditis (IE) not related to intravenous drug abuse (IVDA) in HIV-1-infected patients. Methods We have reviewed the characteristics of eight cases of IE in non-IVDA HIV-1 infected patients
Autor:
Rosa Miquel, Antonio Cardesa, Xavier Claramonte, Jaume Muntané, Pedro Jares, Teresa Ribalta, Julio A. Martinez
Publikováno v:
Virchows Archiv : an international journal of pathology. 440(2)
Cytomegalovirus (CMV) infection remains a highly prevalent systemic complication following orthotopic liver transplantation (LT), accounting for a significant increase in morbidity and affiliated costs. However, unlike other immunosuppressed groups o